Invivyd, Inc.
IVVDNASDAQHealthcare● Active
$1.02
$-0.01(-0.97%)
Market Cap$135384031
P/E Ratio—
52W High$3.07
52W Low$0.483
Invivyd, Inc. (IVVD) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
IVVD · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 14, 2026EPS Actual
-$0.13
Est. -$0.08 · -62.5%
Revenue
$0.01B
Est. $0.02B · -23.8%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 14, 2026
After Market Close
▼ Miss EPS▼ Miss Revenue
IVVD reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.21
Rev. $0.66B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.21
Rev. Est.$0.66B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 13, 2026 | -$0.15 | — | — | — | $0.01B | — |
| ▼ Q2 FY2026 | May 14, 2026 | -$0.08 | -$0.13 | -62.5% | $0.01B | $0.02B | -23.8% |
| ▲ Q1 FY2026 | Mar 5, 2026 | -$0.06 | $0.02 | +133.3% | $0.02B | $0.02B | +0.0% |
| ▼ Q4 FY2025 | Nov 6, 2025 | -$0.05 | -$0.06 | -20.0% | $0.01B | $0.02B | -15.4% |
| ▼ Q3 FY2025 | Aug 14, 2025 | -$0.04 | -$0.12 | -200.0% | $0.01B | $0.03B | -59.4% |
| ▼ Q2 FY2025 | May 15, 2025 | -$0.04 | -$0.14 | -250.0% | $0.01B | $0.02B | -35.4% |
| ▲ Q1 FY2025 | Mar 20, 2025 | -$0.25 | -$0.15 | +40.0% | $0.01B | $0.03B | -59.9% |
| ▼ Q4 FY2024 | Nov 14, 2024 | -$0.33 | -$0.51 | -54.5% | $0.01B | $0.01B | -32.9% |
Q3 FY2026
Aug 13, 2026
EPS Actual
—
EPS Est.
-$0.15
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 14, 2026Miss
EPS Actual
-$0.13
EPS Est.
-$0.08
EPS Surpr.
-62.5%
Revenue
$0.01B
Q1 FY2026
Mar 5, 2026Beat
EPS Actual
$0.02
EPS Est.
-$0.06
EPS Surpr.
+133.3%
Revenue
$0.02B
Q4 FY2025
Nov 6, 2025Miss
EPS Actual
-$0.06
EPS Est.
-$0.05
EPS Surpr.
-20.0%
Revenue
$0.01B
Q3 FY2025
Aug 14, 2025Miss
EPS Actual
-$0.12
EPS Est.
-$0.04
EPS Surpr.
-200.0%
Revenue
$0.01B
Q2 FY2025
May 15, 2025Miss
EPS Actual
-$0.14
EPS Est.
-$0.04
EPS Surpr.
-250.0%
Revenue
$0.01B
Q1 FY2025
Mar 20, 2025Beat
EPS Actual
-$0.15
EPS Est.
-$0.25
EPS Surpr.
+40.0%
Revenue
$0.01B
Q4 FY2024
Nov 14, 2024Miss
EPS Actual
-$0.51
EPS Est.
-$0.33
EPS Surpr.
-54.5%
Revenue
$0.01B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.01 | $0.01 | $0.02 | 1 |
| Q3 FY2028 | $0.01 | $0.01 | $0.01 | 1 |
| Q2 FY2028 | $0.01 | $0.01 | $0.01 | 1 |
| Q1 FY2028 | $0.01 | $0.01 | $0.01 | 1 |
| Q4 FY2027 | $-0.03 | $-0.02 | $-0.02 | 1 |
| Q3 FY2027 | $-0.04 | $-0.03 | $-0.03 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.1B | $0.1B | $0.1B | 1 |
| Q3 FY2028 | $0.1B | $0.1B | $0.1B | 1 |
| Q2 FY2028 | $0.1B | $0.1B | $0.1B | 1 |
| Q1 FY2028 | $0.1B | $0.1B | $0.1B | 1 |
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 14, 2026 | -62.5% | $1.47 | $1.16 | -21.09% |
| ▲ Q1 FY2026 | Mar 5, 2026 | +133.3% | $1.71 | $1.74 | +1.75% |
| ▼ Q4 FY2025 | Nov 6, 2025 | -20.0% | $1.52 | $1.54 | +1.32% |
| ▼ Q3 FY2025 | Aug 14, 2025 | -200.0% | $0.79 | $0.80 | +0.79% |
| ▼ Q2 FY2025 | May 15, 2025 | -250.0% | $0.84 | $0.70 | -15.78% |
| ▲ Q1 FY2025 | Mar 20, 2025 | +40.0% | $0.72 | $0.74 | +2.58% |
| ▼ Q4 FY2024 | Nov 14, 2024 | -54.5% | $0.89 | $0.79 | -11.18% |
| ▼ Q3 FY2024 | Aug 14, 2024 | -8.1% | $1.06 | $0.98 | -7.55% |
Q2 FY2026-21.09%
Report Date
May 14, 2026
EPS Beat/Miss
-62.5%
Price Before
$1.47
Price After
$1.16
Q1 FY2026+1.75%
Report Date
Mar 5, 2026
EPS Beat/Miss
+133.3%
Price Before
$1.71
Price After
$1.74
Q4 FY2025+1.32%
Report Date
Nov 6, 2025
EPS Beat/Miss
-20.0%
Price Before
$1.52
Price After
$1.54
Q3 FY2025+0.79%
Report Date
Aug 14, 2025
EPS Beat/Miss
-200.0%
Price Before
$0.79
Price After
$0.80
Q2 FY2025-15.78%
Report Date
May 15, 2025
EPS Beat/Miss
-250.0%
Price Before
$0.84
Price After
$0.70
Q1 FY2025+2.58%
Report Date
Mar 20, 2025
EPS Beat/Miss
+40.0%
Price Before
$0.72
Price After
$0.74
Q4 FY2024-11.18%
Report Date
Nov 14, 2024
EPS Beat/Miss
-54.5%
Price Before
$0.89
Price After
$0.79
Q3 FY2024-7.55%
Report Date
Aug 14, 2024
EPS Beat/Miss
-8.1%
Price Before
$1.06
Price After
$0.98
Avg Beat Reaction+2.17%
Avg Miss Reaction-8.91%
Beat Rate2 / 8 quarters
Largest Move-21.09% (Q2 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: IVVD ends December
Invivyd, Inc. (IVVD) most recently reported earnings on May 14, 2026 for Q2 FY2026, posting EPS of $-0.13 — missing the analyst consensus of $-0.08 by -62.5%. The next IVVD earnings date is expected around September 1, 2026.
Each quarter, investors track IVVD earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. IVVD revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
IVVD's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
IVVD earnings · 5 questionsInvivyd, Inc.'s next earnings report is expected around September 1, 2026. IVVD typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; IVVD historically reports after market close (AMC).
IVVD earnings datewhen is IVVD earningsIVVD next earnings datewhen does IVVD report earningsIVVD earnings calendar
▸ Source: FMP · Invivyd, Inc. SEC filings · US GAAP · Invivyd, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026